Warning letter
Royal Body Care Inc: warning letter of Feb 12, 2002
FDA warning letter UCM144755 · Dallas District Office
Key facts
| Reference number | UCM144755 |
|---|---|
| Company | Royal Body Care Inc |
| Subject | OTC Drugs, Devices/Adulterated/Misbranded |
| Issue date | Feb 12, 2002 |
| Posted date | Feb 12, 2002 |
| Issuing office | Dallas District Office |
| Product type | Devices |
| CFR sections cited | 807.81(a)(3)(ii), 201.66(b)(2), 820, 807.81(a) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: